Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gliclazide (SE1702), an oral antihyperglycemic agent, belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating beta-cells of the pancreas to release insulin.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
500 mg | 在庫あり | ¥ 10,500 | |||
1 g | 在庫あり | ¥ 16,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Gliclazide (SE1702), an oral antihyperglycemic agent, belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating beta-cells of the pancreas to release insulin. |
ターゲット&IC50 | K+ channel:184 nM |
別名 | S1702, SE1702 |
分子量 | 323.41 |
分子式 | C15H21N3O3S |
CAS No. | 21187-98-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 60 mg/mL (185.5 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gliclazide 21187-98-4 Membrane transporter/Ion channel Potassium Channel KcsA Inhibitor S-1702 inhibit S 1702 SE 1702 SE-1702 S1702 SE1702 inhibitor